{"count": 198, "results": [{"_id": "32702748", "pmid": 32702748, "pmcid": "PMC7544537", "title": "Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom", "journal": "Eur Heart J", "authors": ["Hopewell JC", "Offer A", "Haynes R", "Bowman L", "Li J", "Chen F", "Bulbulia R", "Lathrop M", "Baigent C", "Landray MJ", "Collins R", "Armitage J", "Parish S"], "date": "2020-09-14T00:00:00Z", "doi": "10.1093/eurheartj/ehaa574", "meta_date_publication": "2020 Sep 14", "meta_volume": "41", "meta_issue": "35", "meta_pages": "3336-3342", "score": 50281.51, "text_hl": "Independent risk factors for @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-related @<m>DISEASE_Muscular_Diseases</m> @DISEASE_MESH:D009135 @@@myopathy@@@ and relevance to different types of @<m>DISEASE_Muscular_Diseases</m> @DISEASE_MESH:D009135 @@@muscle symptom@@@", "citations": {"NLM": "Hopewell JC, Offer A, Haynes R, Bowman L, Li J, Chen F, Bulbulia R, Lathrop M, Baigent C, Landray MJ, Collins R, Armitage J, Parish S. Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom Eur Heart J. 2020 Sep 14;41(35):3336-3342. PMID: 32702748", "BibTeX": "@article{32702748, title={Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom}, author={Hopewell JC and Offer A and Haynes R and Bowman L and Li J and Chen F and Bulbulia R and Lathrop M and Baigent C and Landray MJ and Collins R and Armitage J and Parish S}, journal={Eur Heart J}, volume={41}, number={35}, pages={3336-3342}}"}}, {"_id": "33270123", "pmid": 33270123, "pmcid": "PMC7716196", "title": "Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol", "journal": "JAMA Netw Open", "authors": ["Vassy JL", "Gaziano JM", "Green RC", "Ferguson RE", "Advani S", "Miller SJ", "Chun S", "Hage AK", "Seo SJ", "Majahalme N", "MacMullen L", "Zimolzak AJ", "Brunette CA"], "date": "2020-12-01T00:00:00Z", "doi": "10.1001/jamanetworkopen.2020.27092", "meta_date_publication": "2020 Dec 1", "meta_volume": "3", "meta_issue": "12", "meta_pages": "e2027092", "score": 50279.598, "text_hl": "Overall, 120 @SPECIES_9606 @@@participants@@@ (29%) had a @GENE_SLCO1B1 @GENE_10599 @@@SLCO1B1@@@ genotype indicating increased @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ @<m>DISEASE_Muscular_Diseases</m> @DISEASE_MESH:D009135 @@@myopathy@@@ risk. ", "citations": {"NLM": "Vassy JL, Gaziano JM, Green RC, Ferguson RE, Advani S, Miller SJ, Chun S, Hage AK, Seo SJ, Majahalme N, MacMullen L, Zimolzak AJ, Brunette CA. Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol JAMA Netw Open. 2020 Dec 1;3(12):e2027092. PMID: 33270123", "BibTeX": "@article{33270123, title={Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol}, author={Vassy JL and Gaziano JM and Green RC and Ferguson RE and Advani S and Miller SJ and Chun S and Hage AK and Seo SJ and Majahalme N and MacMullen L and Zimolzak AJ and Brunette CA}, journal={JAMA Netw Open}, volume={3}, number={12}, pages={e2027092}}"}}, {"_id": "33608664", "pmid": 33608664, "pmcid": "PMC8159730", "title": "A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy", "journal": "Pharmacogenomics J", "authors": ["Turongkaravee S", "Jittikoon J", "Lukkunaprasit T", "Sangroongruangsri S", "Chaikledkaew U", "Thakkinstian A"], "date": "2021-06-01T00:00:00Z", "doi": "10.1038/s41397-021-00208-w", "meta_date_publication": "2021 Jun", "meta_volume": "21", "meta_issue": "3", "meta_pages": "296-307", "score": 50277.156, "text_hl": "There were some reasons suggesting that individuals who received @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ may have higher risk of @<m>DISEASE_Muscular_Diseases</m> @DISEASE_MESH:D009135 @@@myopathy@@@ than those who took @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Turongkaravee S, Jittikoon J, Lukkunaprasit T, Sangroongruangsri S, Chaikledkaew U, Thakkinstian A. A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy Pharmacogenomics J. 2021 Jun;21(3):296-307. PMID: 33608664", "BibTeX": "@article{33608664, title={A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy}, author={Turongkaravee S and Jittikoon J and Lukkunaprasit T and Sangroongruangsri S and Chaikledkaew U and Thakkinstian A}, journal={Pharmacogenomics J}, volume={21}, number={3}, pages={296-307}}"}}, {"_id": "33316194", "pmid": 33316194, "title": "In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy.", "journal": "Ann Intern Med", "authors": ["Kelsey MD", "Newby LK"], "date": "2020-12-15T00:00:00Z", "doi": "10.7326/ACPJ202012150-071", "meta_date_publication": "2020 Dec 15", "meta_volume": "173", "meta_issue": "12", "meta_pages": "JC71", "score": 50275.645, "text_hl": "In @SPECIES_9606 @@@patients@@@ at high CV risk receiving @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, the @<m>DISEASE_Muscular_Diseases</m> @DISEASE_MESH:D009135 @@@Myopathy@@@ Risk Score predicted statin-related @<m>DISEASE_Muscular_Diseases</m> @DISEASE_MESH:D009135 @@@myopathy@@@.", "citations": {"NLM": "Kelsey MD, Newby LK. In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy. Ann Intern Med. 2020 Dec 15;173(12):JC71. PMID: 33316194", "BibTeX": "@article{33316194, title={In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy.}, author={Kelsey MD and Newby LK}, journal={Ann Intern Med}, volume={173}, number={12}, pages={JC71}}"}}, {"_id": "37031209", "pmid": 37031209, "pmcid": "PMC10082807", "title": "Impact of porous microsponges in minimizing myotoxic side effects of simvastatin", "journal": "Sci Rep", "authors": ["Ali AU", "Abd-Elkareem M", "Kamel AA", "Abou Khalil NS", "Hamad D", "Nasr NEH", "Hassan MA", "El Faham TH"], "date": "2023-04-08T00:00:00Z", "doi": "10.1038/s41598-023-32545-0", "meta_date_publication": "2023 Apr 8", "meta_volume": "13", "meta_issue": "1", "meta_pages": "5790", "score": 50271.438, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SV@@@) is a poorly soluble drug; its oral administration is associated with a significant problem: @<m>DISEASE_Muscular_Diseases</m> @DISEASE_MESH:D009135 @@@Myopathy@@@. ", "citations": {"NLM": "Ali AU, Abd-Elkareem M, Kamel AA, Abou Khalil NS, Hamad D, Nasr NEH, Hassan MA, El Faham TH. Impact of porous microsponges in minimizing myotoxic side effects of simvastatin Sci Rep. 2023 Apr 8;13(1):5790. PMID: 37031209", "BibTeX": "@article{37031209, title={Impact of porous microsponges in minimizing myotoxic side effects of simvastatin}, author={Ali AU and Abd-Elkareem M and Kamel AA and Abou Khalil NS and Hamad D and Nasr NEH and Hassan MA and El Faham TH}, journal={Sci Rep}, volume={13}, number={1}, pages={5790}}"}}, {"_id": "34243595", "pmid": 34243595, "title": "Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: Comprehensive study.", "journal": "Biomed Pharmacother", "authors": ["Abo-Zalam HB", "El-Denshary ES", "Abdelsalam RM", "Khalil IA", "Khattab MM", "Hamzawy MA"], "date": "2021-07-01T00:00:00Z", "doi": "10.1016/j.biopha.2021.111494", "meta_date_publication": "2021 Jul", "meta_volume": "139", "meta_issue": "", "meta_pages": "111494", "score": 50267.363, "text_hl": "Therapeutic advancement of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-loaded solid @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ nanoparticles (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SV@@@-SLNs) in treatment of @DISEASE_Hyperlipidemias @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ and attenuating hepatotoxicity, @<m>DISEASE_Muscular_Diseases</m> @DISEASE_MESH:D009135 @@@myopathy@@@ and apoptosis: Comprehensive study.", "citations": {"NLM": "Abo-Zalam HB, El-Denshary ES, Abdelsalam RM, Khalil IA, Khattab MM, Hamzawy MA. Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: Comprehensive study. Biomed Pharmacother. 2021 Jul;139():111494. PMID: 34243595", "BibTeX": "@article{34243595, title={Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: Comprehensive study.}, author={Abo-Zalam HB and El-Denshary ES and Abdelsalam RM and Khalil IA and Khattab MM and Hamzawy MA}, journal={Biomed Pharmacother}, volume={139}, pages={111494}}"}}, {"_id": "34366626", "pmid": 34366626, "pmcid": "PMC8326251", "title": "Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy", "journal": "World J Gastroenterol", "authors": ["Muñoz AE", "Pollarsky FD", "Marino M", "Cartier M", "Vázquez H", "Salgado P", "Romero G"], "date": "2021-07-28T00:00:00Z", "doi": "10.3748/wjg.v27.i28.4639", "meta_date_publication": "2021 Jul 28", "meta_volume": "27", "meta_issue": "28", "meta_pages": "4639-4652", "score": 50267.168, "text_hl": "Likewise, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ should not be administered to @SPECIES_9606 @@@patients@@@ with @DISEASE_End_Stage_Liver_Disease @DISEASE_MESH:D058625 @@@Model for End-stage Liver Disease@@@ score > 12 and/or Child-Pugh class C because of the high risk of severe @<m>DISEASE_Muscular_Diseases</m> @DISEASE_MESH:D009135 @@@muscle injury@@@. ", "citations": {"NLM": "Muñoz AE, Pollarsky FD, Marino M, Cartier M, Vázquez H, Salgado P, Romero G. Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy World J Gastroenterol. 2021 Jul 28;27(28):4639-4652. PMID: 34366626", "BibTeX": "@article{34366626, title={Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy}, author={Muñoz AE and Pollarsky FD and Marino M and Cartier M and Vázquez H and Salgado P and Romero G}, journal={World J Gastroenterol}, volume={27}, number={28}, pages={4639-4652}}"}}, {"_id": "36613689", "pmid": 36613689, "pmcid": "PMC9820482", "title": "Activation of Transposable Elements in Human Skeletal Muscle Fibers upon Statin Treatment", "journal": "Int J Mol Sci", "authors": ["Valdebenito-Maturana B", "Valdebenito-Maturana F", "Carrasco M", "Tapia JC", "Maureira A"], "date": "2022-12-23T00:00:00Z", "doi": "10.3390/ijms24010244", "meta_date_publication": "2022 Dec 23", "meta_volume": "24", "meta_issue": "1", "meta_pages": "", "score": 50266.555, "text_hl": "Recently, a group of genes and molecular pathways has been described to participate in statin-induced @<m>DISEASE_Muscular_Diseases</m> @DISEASE_MESH:D009135 @@@myopathy@@@, caused by either @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ or @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@, although the mechanism by which changes in gene regulation occur was not studied. ", "citations": {"NLM": "Valdebenito-Maturana B, Valdebenito-Maturana F, Carrasco M, Tapia JC, Maureira A. Activation of Transposable Elements in Human Skeletal Muscle Fibers upon Statin Treatment Int J Mol Sci. 2022 Dec 23;24(1):. PMID: 36613689", "BibTeX": "@article{36613689, title={Activation of Transposable Elements in Human Skeletal Muscle Fibers upon Statin Treatment}, author={Valdebenito-Maturana B and Valdebenito-Maturana F and Carrasco M and Tapia JC and Maureira A}, journal={Int J Mol Sci}, volume={24}, number={1}}"}}, {"_id": "34990819", "pmid": 34990819, "title": "Dynamic urine proteome changes in a rat model of simvastatin-induced skeletal muscle injury.", "journal": "J Proteomics", "authors": ["Wei J", "Huan Y", "Heng Z", "Zhao C", "Jia L", "Yu Y", "Gao Y"], "date": "2022-03-15T00:00:00Z", "doi": "10.1016/j.jprot.2021.104477", "meta_date_publication": "2022 Mar 15", "meta_volume": "254", "meta_issue": "", "meta_pages": "104477", "score": 50264.113, "text_hl": "We therefore examined urine proteome changes associated with @<m>DISEASE_Muscular_Diseases</m> @DISEASE_MESH:D009135 @@@SAMS@@@. Here, we established a @<m>DISEASE_Muscular_Diseases</m> @DISEASE_MESH:D009135 @@@SAMS@@@ @SPECIES_10116 @@@rat@@@ model by intragastric intubation with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (80 mg/kg). ", "citations": {"NLM": "Wei J, Huan Y, Heng Z, Zhao C, Jia L, Yu Y, Gao Y. Dynamic urine proteome changes in a rat model of simvastatin-induced skeletal muscle injury. J Proteomics. 2022 Mar 15;254():104477. PMID: 34990819", "BibTeX": "@article{34990819, title={Dynamic urine proteome changes in a rat model of simvastatin-induced skeletal muscle injury.}, author={Wei J and Huan Y and Heng Z and Zhao C and Jia L and Yu Y and Gao Y}, journal={J Proteomics}, volume={254}, pages={104477}}"}}, {"_id": "32469304", "pmid": 32469304, "title": "Pharmacodynamic evaluation of L-carnitine and piracetam in muscle injury induced by the chronic use of simvastatin.", "journal": "Int J Clin Pharmacol Ther", "authors": ["Dezena RMB", "Antunes NJ", "Campos R", "Ilha J", "Moreno RA", "Mendes GD", "Rosa PCP", "De Nucci G"], "date": "2020-09-01T00:00:00Z", "doi": "10.5414/CP203496", "meta_date_publication": "2020 Sep", "meta_volume": "58", "meta_issue": "9", "meta_pages": "482-490", "score": 50264.086, "text_hl": "Pharmacodynamic evaluation of @CHEMICAL_Carnitine @CHEMICAL_MESH:D002331 @@@L-carnitine@@@ and @CHEMICAL_Piracetam @CHEMICAL_MESH:D010889 @@@piracetam@@@ in @<m>DISEASE_Muscular_Diseases</m> @DISEASE_MESH:D009135 @@@muscle injury@@@ induced by the chronic use of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@.", "citations": {"NLM": "Dezena RMB, Antunes NJ, Campos R, Ilha J, Moreno RA, Mendes GD, Rosa PCP, De Nucci G. Pharmacodynamic evaluation of L-carnitine and piracetam in muscle injury induced by the chronic use of simvastatin. Int J Clin Pharmacol Ther. 2020 Sep;58(9):482-490. PMID: 32469304", "BibTeX": "@article{32469304, title={Pharmacodynamic evaluation of L-carnitine and piracetam in muscle injury induced by the chronic use of simvastatin.}, author={Dezena RMB and Antunes NJ and Campos R and Ilha J and Moreno RA and Mendes GD and Rosa PCP and De Nucci G}, journal={Int J Clin Pharmacol Ther}, volume={58}, number={9}, pages={482-490}}"}}]}